Trial Details
COMPLETEDBasic Information
| Clinical ID | c1229 |
|---|---|
| Identifier | NCT05728008 |
| Trial Title | Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Ustekinumab|DRUG: Tofacitinib |
Participant Information
| Sponsor | IRCCS San Raffaele |
|---|---|
| City | Milano |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2022-04-05 |
|---|---|
| Primary Completion Date | 2022-06-05 |
| Completion Date | 2022-07-05 |